Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose azithromycin for postinfective bronchiolitis obliterans in children
ChiCTR2500106788Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azithromycin in Bronchiolitis Obliterans (BO) (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Clinical symptom severity score at 3 months. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on ChiCTR2500106788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106788.